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ABSTRACT
Poly(C)-binding proteins (CPs) are important regu-
lators of mRNA stability and translational regulation.
TheyrecognizeC-richRNAthroughtheirtripleKH(hn
RNP K homology) domain structures and are thought
to carry out their function though direct protection of
mRNAsitesaswellasthroughinteractionswithother
RNA-binding proteins. We report the crystallograph-
icallyderived structure of the third domain of aCP1 to
2.1A ˚ resolution.aCP1-KH3assumesaclassicaltypeI
KH domain fold with a triple-stranded b-sheet held
against a three-helix cluster in a baabba configura-
tion. Its binding affinity to an RNA sequence from the
30-untranslated region (30-UTR) of androgen receptor
mRNAwasdeterminedusingsurfaceplasmon reson-
ance, giving a Kd of 4.37 mM, which is indicative of
intermediate binding. A model of aCP1-KH3 with
poly(C)-RNAwasgeneratedbyhomologytoarecently
reported RNA-bound KH domain structure and sug-
geststhemolecularbasisforoligonucleotidebinding
and poly(C)-RNA specificity.
INTRODUCTION
aCP1 is a member of the poly(C)-binding protein family of
proteins that include aCP1, aCP2, aCP3, aCP4 (also known
as PCBP and hnRNP E proteins) and the earliest member to
be characterized, the heterogeneous ribonucleoprotein K,
hnRNP K. These proteins contain a triplet K homology
(KH) RNA-binding motif, as ﬁrst identiﬁed in hnRNP K,
which confer speciﬁcity for single-stranded poly(C) tracts
of both RNA and DNA. The two N-terminal domains are
closely spaced, whereas the C-terminal KH domain is separ-
ated by a linking segment of variable length. The aCP family
members are well conserved, with the highest conservation
observed between corresponding KH domains. The main dif-
ferences between aCP family members and their isoforms
occur in the regions between KH domains, which vary in
both sequence and length [for excellent reviews see (1,2)].
The proteins exist in both the nucleus and cytoplasm of the
cell and are involved in a diverse range of functions affecting
the post-transcriptional regulation of speciﬁc genes. These
include the shuttling of mRNA between the nucleus and the
cytoplasm, the stabilization of speciﬁc mRNAs, translational
silencing and translational enhancement. This range of func-
tions, which confer seemingly opposed effects on gene expres-
sion, are likely to be modulated through variation in cellular
conditions, speciﬁc RNA secondary structures and through
interactions with other mRNA-binding proteins.
aCP1 has been studied in particular detail. It has been
implicated in the stabilization of speciﬁc mRNAs, leading
to the upregulation of their gene products. It has been
shown to be sufﬁcient for the formation of the ‘a-complex’
at a speciﬁc C-rich region of the 30-untranslated region
(30-UTR) of a-globin mRNA, causing its accumulation during
terminal erythroid differentiation (3,4). The mechanism of the
mRNA stabilization is thought to be through the mutually
cooperative binding of aCP1 (or other members of the aCP
family) and poly(A)-binding protein at the poly(A) tail, res-
ulting in both inhibition of deadenylation and protection of
a speciﬁc endoribonuclease site, adjacent to the aCP-binding
site, from nucleases (5,6). Interactions between the aCP
protein of the a-complex and the AU-rich element bind-
ing degradation factor AUF1 (hnRNP D) have also been
detected (7).
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motifs have also been implicated in the stabilization of tyr-
osine hydroxylase (8), erythropoietin (9) and b-globin (10)
mRNAs. aCP2 binds with high afﬁnity to a C-rich region
within the 30-UTR of collagen a1(I) mRNA resulting in its
increasedstability (11).aCP1andaCP2have alsobeen shown
to target a speciﬁc UC-rich region of the 30-UTR of androgen
receptor (AR) mRNA. Through cooperative binding with
HuR, these proteins are thought to be a part of the post-
transcriptional control mechanism for the AR expression (12).
aCP proteins have also been shown to effect translational
control. Their binding to a CU-rich region of the 30-UTR
differentiation control element of 15-lipoxygenase mRNA
along with hnRNP K suppresses the translation in erythroid
cells until the terminal stages of erythroid differentiation (13).
This occurs through interference with the joining of the ribo-
somal 60S and 40S subunits at the initiation AUG codon (14).
Similarly,humanpapillomavirus type 16L2 mRNA appears to
be silenced via binding to aCP proteins (15), though the L2
sequence is not so C-rich. In contrast, translational enhance-
ment has been reported due to aCP binding to two sites of the
50-UTR of picornavirus RNA. aCP binds to the 50-terminal
cloverleaf structure of stem–loop I, and to a C-rich region of
the stem–loop IV of the internal ribosome entry site resulting
in the cap-independent translation of the gene (16,17). Further
aCP-mediated effects on translation have also been reported
for otherviralsystems (18,19). Thus, aCP binding to RNA can
result in both silencing and enhancement of translation
through a diverse array of pathways.
The speciﬁcity of aCP proteins for poly(C)-
oligonucleotides is conferred through their KH domains.
These domains were originally deﬁned by the repeated
45 amino acid motif identiﬁed in hnRNP K (20). A more
extensive 68–72 amino acid motif has since been deﬁned
(21). The 3D structures of several KH domains have been
determined, both in the absence (21–24) and in the presence
of RNA or ssDNA (25–27). Two structural subtypes have been
identiﬁed, type I possesses the 45 residue core baab motif
plus a C-terminal ba extension, whereas type II possesses the
core and an N-terminal ab extension (28). The aCP KH
domains, like the hnRNP K, are type I and thus comprise a
three-stranded anti-parallel b-sheet packed against three
a-helices (baabba). Oligonucleotide binding by KH domains
occurs primarily via hydrophobic interactions through a
groove bounded by two unstructured surface loops. The
loop between a-helices 1 and 2 contains an invariant GXXG,
crucial to oligonucleotide binding; that between b-strands 2
and 3 is of variable length and sequence and ﬂanks the RNA-
binding groove (25).
The relative contributions by the three KH domains in the
aCP proteins to RNA-binding afﬁnity and speciﬁcity are not
yet clearly understood. While all three of the individual KH
domains of hnRNP K have been shown to contribute signiﬁc-
antly to poly(C) binding (29), only the ﬁrst and third KH
domains of aCP1 and aCP2 have been shown to independ-
ently bindpoly(C)-RNA with highafﬁnity andspeciﬁcity(30).
It may be, however, that the second KH domain also binds
poly(C)-RNAwhentethered by its neighbouring domains. The
aCP-binding motif within the a-globin 30-UTR contains three
C-rich patches. The disruption of any of these interferes with
the a-complex formation and decreases a-globin stability
in vivo (3,31). Likewise, the optimal target sequence of the
closely related aCP-2KL isoform generated by in vitro
SELEX contained three short C-patches within an exposed
single-stranded conformation (32). This suggests that op-
timum binding by aCP proteins may be achieved via the
interaction of all three KH domains with poly(C)-regions. It
is not yet known, however, how these individual KH domains
could be juxtaposed to facilitate such binding.
The current study describes the overexpression, crystalliza-
tion and structure determination of the third KH domain of
aCP1 solved to 2.1 A ˚ resolution using X-ray crystallography.
This represents the ﬁrst structure of an aCP1 domain to be
structurally analysed. We also verify its RNA-binding
capacity to a target RNA sequence using surface plasmon
resonance and present a model of its interaction with
poly(C)-oligonucleotides, based on a homologous KH domain
bound to RNA. This has provided insight into the basis for the
poly(C)-binding speciﬁcity of aCP1-KH3 and is the ﬁrst step
towards the structural deﬁnition of the full-length protein.
MATERIALS AND METHODS
Protein expression and purification
The third KH domain of aCP1 (KH3) was expressed as a
fusion protein with glutathione-S-transferase (GST). The
DNA coding sequence comprising amino acids 279–356 of
aCP1 were cloned into pGEX-6P2 plasmids and expressed by
the Escherichia coli BL21 (Codon+) cell line in Luria broth at
37 C. Protein expression was induced with 0.02 mM isopro-
pyl-b-D-thiogalactopyranoside at an optical density of 0.8 at
595 nm. The cells were harvested after 3 h further growth by
centrifugation and resuspension in phosphate-buffered saline
(PBS) (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
1.8 mM KH2PO4, pH 7.4) containing 0.5% Triton X-100.
They were then lysed by French Pressing (SLM Instruments,
Inc.), supplemented with 0.5 mM phenylmethlysulfonyl ﬂu-
oride. aCP1-KH3 was puriﬁed by afﬁnity chromatography
using glutathione agarose beads equilibrated with PBS buffer
and the GST removed using 2 U Prescission protease (Amer-
sham) in 50 mM Tris–HCL, pH 7.0, 150 mM NaCl, 1 mM
EDTA and 1 mM DTT. Size exclusion chromatography using
a Sephadex 75 column (Pharmacia) was used as the ﬁnal
puriﬁcation step of aCP1-KH3 after dialysis into phosphate
buffer, pH 6.0 (1 mM DTT, 25 mM phosphate, 150 mM NaCl
and 1 mM EDTA). The puriﬁed protein was concentrated
to 5 mg/ml with centrifugal concentrators of 3 K cutoff
(Millipore) and quantiﬁed using a detergent compatible
(Biorad) protein assay.
Crystallization of aCP1-KH3
Crystals of aCP1-KH3 were grown using vapour diffusion in
2 ml hanging drops containing 1:1 mixtures of protein and
reservoir solutions. The protein solution contained 5.0 mg/ml
of protein in 25 mM potassium phosphate, pH 6.0, 1 mM DTT,
1 mM EDTA and 150 mM NaCl, and the reservoir solution
was composed of 0.1 M Na HEPES, pH 7.5 in 1.5 M lithium
sulphate–Hampton Crystal Screen reagent formulation num-
ber 16 (Hampton Research, CA). Crystals typically grew in
2 days to dimensions of  0.3 · 0.2 · 0.02 mm with the outline
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resolution.
X-ray data collection
Data were recorded with a Rigaku R-Axis V imaging plate
detector mounted on a Rigaku RU-200 rotating anode gener-
ator with a Cu target and focusing mirror optics. Flash freezing
was carried out in a stream of cold nitrogen gas. Prior to ﬂash-
freezing at 100 K, the crystals were passed through a solution
of the reservoir solution modiﬁed to include 15% glycerol as a
cryoprotectant. Data were integrated and scaled with DENZO
and SCALEPACK (33). Structure factor amplitudes were cal-
culated using TRUNCATE (34). The data collection statistics
are given in Table 1.
Structure solution and refinement
The structure of aCP1-KH3 was solved by molecular replace-
ment using the coordinates of the Nova-2 KH3 RNA-binding
domain (accession no. 1EC6) as the search model as imple-
mented in AMORE (34). With one molecule of aCP1-KH3
per asymmetric unit, the estimated solvent content of the crys-
tals is 39%. Matthew’s Coefﬁcient was calculated as 2.0,
which is within the normal range of proteins (35). Success
with molecular replacement was achieved using space group
P21212, which was also consistent with observed systematic
absences. Molecular replacement with other primitive ortho-
rhombic space groups was not successful. Cycles of manual
model building and reﬁnement were carried out using
REFMAC (34). A total of 10% of the reﬂections were used
for Rfree calculations. The ﬁnal model, containing 74 amino
acid residues of the aCP1-KH3 construct and 55 water
molecules, has a crystallographic Rcryst of 21.4% (Rfree =
25.4%) with 96% of all amino acids within the most favour-
able region of a Ramachandran plot. All residues were visible
in the electron density map except the N-terminal glycine and
the C-terminal eight residues (SEKGMGCS) present in the
construct, as conﬁrmed by mass spectrometry (measured
MW 8525; expected MW 8552.72). The ﬁnal model has
been deposited with the Worldwide Protein Data Bank
(accession no. 1WVN).
RNA-binding studies
Surfaceplasmon resonance (using aBIAcore 2000instrument)
was employed to characterize the aCP1-KH3 interaction with
RNA. A research grade chip coated with streptavidin was
purchased from BIAcore. The target 50-biotinylated mRNA
(mRNA: 50-CUCUCCUUUCUUUUUCUUCUUCCCUCC-
CUA-30) representing nt 3296–3325 of AR mRNA was
obtained from Dharmacon and immobilized on the second
ﬂow cell as the captured molecule. The ﬁrst ﬂow cell coated
with only streptavidin was used as the reference surface. The
immobilization steps were carried out at a ﬂow rate of
10 ml/min in running buffer, 10 mM Tris–HCl, pH 7.4,
150 mM NaCl, 0.5% Triton X and 2 mM DTT, 2 mM
EDTA, 125 mg/ml tRNA and 62.5 mg/ml BSA. An average
of 30 RU of RNA was immobilized on ﬂow cell 2. aCP1-KH3
was injected over ﬂow cells 1 and 2 with concentrations of 10,
5, 2.5, 1.25 and 0.625 mM for 2 min using a ﬂow rate of
50 ml/min. All experiments were duplicated (or performed
multiple times) to determine the reproducibility of the signal.
Regeneration involved removal of the bound protein from the
streptavidin chip with a 2 min wash at 20 ml/min with 2 M
NaCl. Data were analysed with the BIAevaluation software to
obtain a binding constant using a steady-state model.
Modelling of aCP1-KH3 bound to
poly(C)-oligonucleotide
The aCP1-KH3 structure was superposed with the structure of
Nova2-KH3 bound to RNA (accession no. 1EC6) (25) using
LSQMAN (36). In this way, the coordinates of oligonuc-
leotides (9–16) could be extracted and used to generate an
8 nt poly(C)-RNA docked to the aCP1-KH3 structure
(using the Insight II software package to change the bases
to cytosine). The structure was subjected to molecular
dynamics simulations using NAMD (37) in a fully solvated
box, with overall neutral charge (through the addition of
randomly placed sodium ions). The complex structure was
allowed to equilibrate in 10
6 fs time steps using the
CHARMM27 energy forceﬁeld (38) at 310K and 1 atm
using periodic boundary conditions. This ensured that there
were no steric clashes in the ﬁnal model and allowed a full set
of possible intermolecular interactions to be viewed. The ste-
reochemistry of the oligonucleotide and the intermolecular
hydrogen bond formation during the simulation were recorded
at picosecond intervals for analysis (see Supplementary
Material).
RESULTS
Structural overview
The aCP1-KH3 adopts a classic KH type I domain fold (28),
with a triple-stranded b-sheet held against a three-helix cluster
in a baabba conﬁguration (Figure 1A). The b-sheet is anti-
parallel and displays the usual left-handed twist. From its inner
surface emanate numerous hydrophobic residues which con-
tribute both to the hydrophobic core and the oligonucleotide
Table 1. Data collection and refinement statistics
Data collection
Symmetry P21212
Unit cell (A ˚) a = 33.4
b = 71.0
c = 29.1
Measured reflections 14721
Unique reflections 4310
Completeness (%) 98.1 (87.2)
Rmerge(%) 5.7 (25.8)
Wilson B (A ˚ 2) 28.2
Refinement
Resolution range (A ˚) 35.0–2.1
Rcryst (%) 21.4
Rfree (%) 25.4
r.m.s. deviation from ideal values
Bond length (A ˚) 0.012
Bond angle ( ) 1.3
Average temperature factor (A ˚ 2) 26.1
Number of water molecules 55
Values in parentheses are for the last resolution shell (2.16–2.1 A ˚).
Rmerge=jI <I>j/<I>whereIistheobserveddiffractionintensityand<I>is
the average diffraction intensity from several measurements of one reflection.
Rcryst = jFoj  jFcj/jjFoj where jF0j and jFcj are the observed and
calculated structure factors, respectively.
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vides the complementary hydrophobic surface within this
compact motif. The N-terminal four residues in the model
(PLGS) are not shown. These residues, which are not part
of the aCP1 sequence but present due to cloning procedures,
adopt a random coil structure.
b-strand 1 commences with the ﬁrst native amino acid res-
idue, Gln5. This strand extends the length of the molecule and
projects residues Leu10 and Ile12 into the hydrophobic core,
before breaking into a turn at Pro13. a-helix 1 is held in
position through its hydrophobic face (including Leu16,
Ile17, Ile20 and Ile21) before its structure is interrupted by
the invariant GXXG sequence (Figure 1B, blue) that is essen-
tial to the KH domain oligonucleotide-binding site. In the case
of aCP1-KH3, where RQ ﬁlls the XX positions, these side
chains are projected outward and provide a hydrophobic edge
of the oligonucleotide-binding cleft. Numerous hydrophobic
side chains also emanate from a-helix 2 to form contacts with
the inner face of the b-sheet, and to provide a hydrophobic
environment for oligonucleotide binding (Ile 28, Ile31 and the
aliphatic chain of Arg32). Gly36 facilitates a break from hel-
ical secondary structure and the remaining two strands of the
b-sheet follow. They provide hydrophobic core residues Ile39,
Ile41, Arg51, Val53 and Ile55.
b-strands 2 and 3 are separated by the ‘variable loop’
(Figure 1B, pink) which bulges slightly away from the
b-sheet and forms the opposing edge of the narrow
oligonucleotide-binding cleft. This is the region of the greatest
sequence variability between KH domains. The C-terminal
helix extends the length of the main body of the molecule
with residues Ile62, Leu68, Ile69, Arg72 and Leu73 projected
into the hydrophobic core or towards adjacent a-helix 2.
a-helix 3 is not visible over the last six residues, due to
high mobility.
The oligonucleotide-binding cleft
The oligonucleotide-binding site has long been supposed to
involve the GXXG motif. This has been conﬁrmed through
the recent structural analysis of four KH domains in the
presence of oligonucleotide. These include Nova2-KH3 in
the presence of a 20 base loop of RNA (25), hnRNPK-KH3
solved with a 10 base stretch of ssDNA (26) and KH3/4 do-
mains of FBP solved in the presence of a 29 base ssDNA
(27). In each of these cases, the main oligonucleotide contacts
have been made with the narrow hydrophobic cleft that
runs between a-helix 2 and b-sheet 2 and across the GXXG
motif. It is thought that the narrowness of the cleft confers
the speciﬁcity of these KH domains for pyrimidines.
Likewise, aCP1-KH3 possesses a narrow hydrophobic cleft
that would be expected to accommodate pyrimidine-rich RNA
or ssDNA.
The edges of the cleft are polar and charged with basic side
chains (Arg23, Arg 32, Lys40 and Arg51) providing attractive
electrostatic forces for both the docking of the oligonucleo-
tide as well as making speciﬁc contacts with the oligonuc-
leotide (see further discussion below). The electrostatic
potential emanating from aCP1-KH3 was calculated using
the Adaptive Poisson–Boltzmann Solution (APBS) software
package (http://agave.wustl.edu/apbs/) (39–43) and is shown
in Figure 1C. The contours represent a numerical solution to
the Poisson–Boltzmann equation (44,45) and simulate the
sum total of the electrostatic potential of the molecule in
salty aqueous media. The outstanding feature of the calcula-
tion is the positive potential arising precisely from the
oligonucleotide-binding cleft (blue contour). This positive
potential would provide an attractive force for the approach
of the oligonucleotide since its potential is dominated by the
electronegative phosphate backbone.
Comparison with other KH domain structures
aCP1-KH3 shows high structural similarity to other type I KH
domains. The seven most similar KH structures, including
hnRNP K (24,26), Nova2-KH3 and Nova1-KH3 (23,25),
FBP-KH3 and FBP-KH4 (27), vigilin-KH6 (21) and FMR-
KH1 (22), are shown superimposed in Figure 2A (in the
case of NMR-derived structures, the ﬁrst chain in the PDB
Figure 1. ThecrystalstructureofaCP1-KH3(residues279–356) solvedto2.1 A ˚ resolutiondepictedin (A) cartoonformand (B) asa molecularsurfacein thesame
orientation.Thestructureisshownfromthebeginningofb-strand1totheendofa-helix3,sincetheregionsoutsidetheseboundswererandomcoilornotvisiblein
thedensity.TheGXXGmotif,commontothisoligonucleotide-bindingmotif,iscolouredblue.The‘variableloop’regionbetweenb-sheets2and3iscolouredpink.
These regions bound the hydrophobic oligonucleotide-binding cleft that accommodates C-rich RNA or ssDNA. (C) The electrostatic potential emanating from the
aCP1-KH3structurecalculatedusingtheAPBSsoftwarepackage(http://agave.wustl.edu/apbs/)(39–43).Potentialcontoursareshownat+1kT/e(blue)and 1kT/e
(red) and obtained by solution of the linearized Poisson–Boltzmann equation at 150 mM ionic strength with a solute dielectric of 2 and a solvent dielectric of 78.5.
The blue contour represents a striking positive potential directing oligonucleotides to the binding cleft.
1216 Nucleic Acids Research, 2005, Vol. 33, No. 4ﬁle is depicted). Their backbone traces are highly convergent
with pairwise root-mean-square deviation (RMSD) scores
compared with aCP1-KH3 over the matched regions (accord-
ing to LSQMAN) <1.8 A ˚. Vigilin-KH6 and FMR-KH1 show
the greatest deviations, with several stretches of backbone fold
unmatched toregions within aCP1-KH3(>3.5 A ˚ away). These
include the variable loop and the region about the GXXG
motif, which are also the regions that show the least deﬁnition
in the NMR-derived structures.
Figure 2B shows the deviations numerically, with a-carbon
distances from matched aCP1-KH3 residues plotted against
the aCP1-KH3 residue number. The divergent regions are
shown as off-scale in this plot. The KH structures are
superimposed with most a-carbon atoms within 2 A ˚ of
the corresponding aCP1-KH3 atom. Apart from Vigilin-
KH6 and FMR-KH1, greater deviations only occur at the
termini and variable loop region between b-sheets 2 and 3.
A subtle variation also occurs at the GXXG motif possibly
reﬂecting the inherent ﬂexibility of the glycines. It is remark-
able that these KH domains retain such high structural
similarity and yet possess distinct oligonucleotide-binding
preferences.
aCP1-KH3 shows the greatest structural similarity to its
fellow poly(C)-binding family member, hnRNP K, with an
RMSD of 0.63 A ˚. A structure-based sequence alignment of
these KH domains with the others serves to highlight the
conservation of residues reportedly underlying oligo-
nucleotide binding (Figure 3). In particular, residues about
the GXXG motif as well as those in the b-strand 2
provide the main contact surface. Of these, Ile 20, Ile 21,
Ile28 and Ile 41 are highly conserved as bulky hydrophobic
residues, and Gly18, Gly22 and Gly25 are integral to the
oligonucleotide-binding motif. Basic residues Arg23 and
Arg51 have also been shown to be involved in the
oligonucleotide-binding interaction and basic residues are
retained at these positions except in Vigilin-KH6 and
FMR-KH1.
RNA-binding studies
The binding of aCP1-KH3 to a 30 nt UC-rich sequence from
the 30-UTR of AR mRNA (nt 3296–3325) was examined using
surface plasmon resonance. This sequence was derived from a
51 nt sequence (nt 3275–3325) shown to be an aCP1 target
using aCP1 antibody supershift identiﬁcation of the compon-
ents of LNCaP cellular extract binding to the AR mRNA
construct (12). Since the aCP1 binding was localized to the
30-CCCUCCCsequenceinthisUC-richstretch, weutilizedthe
30 30 nt sequence as our target RNA. The protein, as prepared
using our reported method, was determined to be fully folded
and capable of binding RNA completely using NMR titration
methods (46). The protein was injected over a biosensor to
which puriﬁed biotinylated RNA had been immobilized. The
bindingcurvesareillustratedinFigure4,andarecharacteristic
of a fast kinetics macromolecular interaction. A simple 1:1
Langmuirmodelcouldnotbeﬁttedtothe curvesduetothe fast
binding kinetics at the start and ﬁnish of the protein injection
period, so reliable association and dissociation constants could
not be determined. An equilibrium analysis of the data, how-
ever, yielded a Kd value in the mM range (4.37 mM), which is
indicative of intermediate binding. This is in contrast to the
tight binding (Kd   28 nM) determined for the full-length
protein binding to the 51 nt AR mRNA construct using
REMSA (12). While this may be an overestimate due to
Figure 2.ComparisonofKHdomainstructures.(A)BackbonetraceofaCP1-KH3(grey)showninstereosuperimposedwiththoseofotherKHdomainstructuresas
listed.TheseincludeKHdomainstructuresbothintheabsenceandpresenceofboundoligonucleotide.(B)Thea-carbondeviationforeachKHdomainresiduefrom
thecorrespondingalignedresidueofaCP1-KH3isplottedversustheaCP1-KH3residuenumber.Aminoacids>3.5A ˚,orwithnocorrespondingalignedresidue,are
indicated with an off-scale score (>5).
Nucleic Acids Research, 2005, Vol. 33, No. 4 1217the absence of non-speciﬁc binding competitors used in this
study, the tighter binding of full-length protein suggests that
multiple KH domains of aCP1 are likely to be participating
synergistically in binding the target RNA (12).
Model of aCP1-KH3 bound to poly(C)-oligonucleotide
The high degree of similarity of aCP1-KH3 to Nova2-KH3
has permitted its interaction with poly(C)-RNA to be
Figure 4. InteractionoftheaCP1-KH3withthe30nt ofthe30-UTRofARmRNAmeasured bysurfaceplasmonresonance.(A) 30RURNAwasimmobilizedona
streptavidin-coated chip. Binding interactions were measured for a series of dilutions of the aCP1-KH3 domain from 10 to 0.625 mM for 2 min using flow rate of
50 ml/min. (B) Steady-state analysis of the interaction yielded a Kd value of 4.37 mM.
Figure 3. Structure-based sequence alignment of seven KH domains of high structural similarity to aCP1-KH3. Each KH domain was structurally aligned using
LSQMAN(36)againstaCP1-KH3.Aminoacidresidueswitha-carbonpositionswithin3.5A ˚ ofacorrespondingaCP1-KH3residueareshowninblack.Highlighted
inpurplearetheaminoacidresiduesthatdonotalignwellwithresiduesofaCP1-KH3.Secondarystructuralelements,asdefinedinLewisetal.,(23)areshownabove
thecorrespondingsequenceincartoonform.Parenthesizednumbersrepresenttheaminoacidnumbersatthestartandfinishofthesuperimposedcoreregionforeach
structure,andindicatetheextentofthestructureusedtocalculatesequenceidentitywithaCP1-KH3(finalcolumn).TheGXXGmotifandthevariableloopregions
are blocked with grey. Amino acid residues reported to make contact with the oligonucleotide [in the cases of structures determined in complex with either RNA or
ssDNA(25–27)]arehighlightedinred,andtheaCP1-KH3predictedtomakecontactwitholigonucleotideinthecurrentstudyarehighlightedintan.NMRstructures
were structurally aligned on the basis of the first chain in the deposited PDB coordinate file and all were deemed to be representative of the set of structures.
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complexed with a 20 base stem–loop RNA (25) as well as
in its uncomplexed forms (23). Oligonucleotide binding
incurred no signiﬁcant structural differences in the backbone
conformation, suggesting that the aCP1-KH3 structure may
also represent a close approximation of its oligonucleotide
bound form. Poly(C)-RNA was therefore positioned in the
binding cleft of aCP1-KH3 by analogy to this structure to
help predict interactions that may underlie its poly(C)-
binding speciﬁcity. The poly(C)-RNA is positioned along
the hydrophobic cleft and across the GXXG motif with four
bases making most of the contacts with the binding site. The
orientation of the oligonucleotide is with the sugar–phosphate
backbone directed towards the helix edge of the cleft and the
bases, planar to the protein surface and pointing towards the
centre and b-sheet 2 (Figure 5A).
Figure 5B summarizes the possible electrostatic and hydro-
phobic contacts between aCP1-KH3 and RNA. These were
determined with allowance for some molecular ﬂexibility (as
assessed using molecular dynamics simulations using the
CHARMM27 energy forceﬁeld). They include non-speciﬁc
hydrophobic interactions with Ile17, Gly18, Cys19, Ile21,
Ile 28 and Ile41, which form the surface of the binding
cleft, as well as numerous electrostatic contacts to the
sugar–phosphate backbone involving Gly22, Arg23, Gln24,
Gly25 backbone atoms (the GXXG tetrad) and contact with
the Cyt4 sugar hydroxyl by the Lys40 side chain amino group.
Interactions that may help to favour pyrimidine binding
include Arg 32 and Arg51 guanidino groups positioned in
close proximity to pyrimidine carbonyls (C2 carbonyls in
Cyt3 and Cyt2, respectively; Figure 5C). Interactions that
could underlie cytosine speciﬁcity include potential hydrogen
bonds between Ile28 and Ile41 side chains and the central two
cytosine bases (via their O2, N3 and N4 atoms). These iso-
leucines are conserved in hnRNP K and form an extensive
methyl–oxygen and methyl–nitrogen hydrogen bond network
with the equivalent bases in ssDNA (26). In addition, several
water-mediated hydrogen bonds between the protein and RNA
occur ﬂeetingly during the simulation. In particular, Ile41
carbonyl oxygen alternates between being hydrogen bonded
to Cyt4 carbonyl and sugar hydroxyl groups, and thus con-
tributes to the preference for ribopyrimidyl oligonucleotide. A
summary of the occurrences of each hydrogen bond and water-
mediated hydrogen bond during the 1 ns molecular dynamics
simulation is provided as Supplementary Material.
Poly(C)-RNA structure may favour binding
Many of the aCP1-KH3-oligonucleotide contacts would be
predictedtooccur uponeither RNA or ssDNA binding, suchas
the hydrophobic contacts listed above and electrostatic inter-
actions with Gly25, Arg51 and Lys40. Other contacts are
precluded from occurring in the case of ssDNA, due to the
absence of sugar hydroxyl groups. These include potential
hydrogen bonds between sugar hydroxyls and Gly25,
Arg32, Arg51 and Lys40 as well as water-mediated hydrogen
bonds as mentioned above.
Inter-nucleotide phosphate hydrogen bonds may also
impact on the RNA structure and potential interactions with
aCP1-KH3. Phosphates of nt 2 and 4 can hydrogen bond to
sugar hydroxyls of nt 2 and 3, respectively. Phosphates of nt 1
and 3, on the other hand, may hydrogen bond to Cyt1 and Cyt4
amino groups. The former of these interactions are unique to
RNA and the latter are also cytosine speciﬁc. Thus, it may be
that the uniquely stable conformation of RNA in this binding
Figure 5. (A) Molecular surface of aCP1-KH3 showing modelled position of
poly(C)-RNA(orange)basedontheNova2-KH3-RNAstructure(accessionno.
1EC6).Thepoly(C)-tetradisviewedfromabovetheGXXGandvariableloops,
highlighting their position either side of the hydrophobic binding cleft. (B)
SummaryofpotentialinteractionsoccurringbetweenthemodelledaCP1-KH3
andpoly(C)-RNA.Apoly(C)-RNA-tetradisrepresentedschematically.Poten-
tial hydrogen bond interactions are indicated by dotted lines. Those from
specific residue atoms to the RNA backbone are listed on the right, and those
to the cytosine bases are listed on the left. The red dotted lines represent intra-
molecularhydrogenbondsthatmaystabilizetheRNAinitsbindingmodetothe
KH domain. Hydrophobic or van der Waals contacts to the cytosine bases are
indicatedby solid lines.(C) The positionsof Arg32 and Arg51 side chainsare
highlighted beneath the molecular surface of aCP1-KH3. Potential hydrogen
bonds to the poly(C)-RNA are shown as dotted lines.
Nucleic Acids Research, 2005, Vol. 33, No. 4 1219cleft,andinparticularthatofpoly(C)-RNA,favoursbindingto
the KH domain.
DISCUSSION
aCP1-KH3 is reported to preferentially bind poly(C)-RNA
over other bases and over ssDNA (30), though the ssDNA
sequence is not clearly speciﬁed in this study. The crystal
structure of this domain conﬁrms its adoption of the classical
type I KH fold and has allowed a precise model of its inter-
actions with poly(C)-RNA to be examined. Speciﬁcity for
pyrimidines can be understood in terms of its narrow binding
cleft that would only readily accommodate the smaller bases.
Speciﬁcity for cytosines over uracil or thymine can also be
rationalized on the basis of speciﬁc hydrogen bond inter-
actions to cytosine C2 carbonyl, N3 and C4 functionalities.
Preferential binding to RNA over ssDNA would be explained
in part by sugar hydroxyl intermolecular hydrogen bonding. It
may also be that a poly(C)-RNA oligonucleotide is able to
contour perfectly in the binding cleft, with inter-nucleotide
hydrogen bonds from sugar hydroxyls stabilizing this con-
formation. On the other hand, C-rich ssDNA has been
shown to adopt very similar interactions with hnRNP K,
and is reported to bind just as well, if not better, than RNA
to this closely related KH domain (26).
This study has shown that oligonucleotide binding by
aCP1-KH3 is likely to involve extensive interactions with
only four bases. The question remains as to how adjacent
KH domains are arranged when full-length aCP1-KH3
binds to RNA. It may be that the KH domains are able to
bindinrelativelycloseproximity.Indeed,thetwoadjacent KH
domains (KH3 and KH4 of FBP) were shown to contact
stretches of 6–7 bases, respectively, with only 5 bases in
between (27). In addition, the consensus binding sequence
for the aCP-2KL isoform involves three C-rich stretches
(of 3–5 bases) separated by 2–6 A/U stretches (32). Thus,
aCP binding may well involve participation by all three
KH domains.
This study represents the beginning of a structural and bio-
physical examination of all three KH domains of aCP1. The
basis for RNA-binding afﬁnity and speciﬁcity of the three KH
domains will allow us to predict the occurrence of aCP1
interactions with mRNA and better understand the multi-
KH domain binding complex. A comparison with the other
aCP isoforms will also be of interest. To date, little is known
about their oligonucleotide-binding preferences and differ-
ences in their binding afﬁnities to RNA. Further analyses
will help us to rationalize the role of the whole aCP family
in mRNA stability and translational efﬁciency.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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